With the rapid influx of new oncology drugs and innovative treatments entering the market, there is a greater urgency to examine the impact of payer-provider payment reform on overall oncology costs and patient outcomes. Now in its 14th year, CBI’s Value-Based Oncology Management convenes payers, providers, PBMs, manufacturers and specialty pharmacies to discuss current trends, challenges and best practices to bend the oncology cost curve, enhance the quality of care and improve patient outcomes.